FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Rubio teases details of potential Trump, Putin in-person meeting after Russia-Ukraine ceasefire talks stall

Bipartisan Warning: Americans Should Brace for a Brutal Summer Vacation

Hitchhiker’s Guide to where the ‘big, beautiful bill’ stands, and what happens Sunday in the Budget Committee

Murphy says one ‘can’t defend’ Democratic Party’s 2024 actions

Major Union Just Put a Huge Hurdle in Front of Embattled Trump Pick: Report

Al Green suggests military coup coming under Trump, refuses to pivot from attacks

Dems’ hearing meltdowns a play to the base, analysts say, as Trump noms keep pushing back in viral moments

Teen Acquitted of Mom’s Murder Two Years After Allegedly Killing His Father

Zelensky sheds details on meeting with Vance, Rubio in Rome after Russia peace talks stall

Angel Reese Has to Be Held Back After Caitlin Clark Takes Her Down with Flagrant Foul

McCarthy suggests Trump doing Johnson’s job as speaker after ‘big beautiful bill’ crashes in House

Vance meets Pope Leo XIV in Vatican City for inauguration mass

Watch: Woman Pulls Down Police Barrier, Drives Through Crowded Street Festival

Near 50-Year-Old Cold Case Heats Up After Feds Double-Check Cigarette Pack

FOIA staffing cuts endanger future of government transparency

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”